Glucose metabolism reprogramming in gynecologic malignant tumors

Area of Science:

• Oncology
• Metabolic Research
• Gynecology

Background:

• Gynecologic tumors show increased metabolic activity, particularly in glycolysis.
• Factors like obesity and viral infections contribute to rising cancer incidence.
• Tumor cell glycolysis influences malignant behavior through specific mechanisms.

Purpose of the Study:

• To review the link between abnormal glucose metabolism and gynecologic tumors.
• To elucidate the role of glycolytic proteins, molecules, and pathways in tumorigenesis.
• To provide insights for early screening, diagnosis, treatment, and recurrence prevention.

Main Methods:

• Literature review of studies on glucose metabolism and gynecologic cancers.
• Analysis of the correlation between glycolysis and cervical cancer (CC), endometrial carcinoma (EC), and ovarian cancer (OC).
• Examination of signaling pathways and regulatory molecules involved in tumor metabolism.

Main Results:

• Abnormal glucose metabolism is a significant factor in the development and progression of CC, EC, and OC.
• Specific glycolytic proteins and pathways are implicated in malignant behavior.
• Understanding these metabolic alterations offers therapeutic targets.

Conclusions:

• Targeting abnormal glucose metabolism presents a promising strategy for gynecologic cancer treatment.
• Insights into tumor glycolysis aid in developing interventions for early detection and recurrence prevention.
• Further research into metabolic pathways can enhance patient outcomes for gynecologic malignancies.